N/A
Completed N=46
Continuous And Pulsed Ultrasound Treatments On Carpal Tunnel Syndrome
Source: ClinicalTrials.gov NCT02054247 ↗Enrolled (actual)
46
Serious AEs
0.0%
Results posted
Nov 2023
Primary outcomePrimary: Change From Baseline in Symptom Severity With Symptom Severity Scale — 23.06; 22.06; 19.66 units on a scale — p=0.442
Summary
The aim of this placebo-controlled study was to evaluate the effects of pulsed and continuous ultrasound treatments combined with splint therapy on patients with mild and moderate idiopathic carpal tunnel syndrome
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change From Baseline in Symptom Severity With Symptom Severity Scale |
23.06; 22.06; 19.66 | 0.442 |
| SECONDARY Change From Baseline in Pain With Visual Analogue Scale |
4.40; 2.68; 3.53 | 0.083 |
| SECONDARY Change From Baseline in Functional Status With Functional Status Scale |
18.8; 19.31; 14.2 | 0.125 |
| SECONDARY Changes From Baseline Nervus Medianus Motor Conduction Velocity |
54.26; 55.68; 57.91 | 0.146 |
Eligibility Criteria
Inclusion Criteria
- Mild or moderate idiopathic carpal tunnel syndrome (without thenar atrophy or spontaneous activity on electrophysiological examination of the abductor pollicis brevis (APB) muscle)
Exclusion Criteria
- Secondary entrapment neuropathies
- Cervical radiculopathy
- Systemic diseases with increased risk of the carpal tunnel syndrome
- Gained surgical relief of the syndrome
- Treated with ultrasound for the syndrome
- A history of steroid injections into the carpal tunnel and of physical therapy within the last 3 months
- Patients with either thenar atrophy or spontaneous activity (fibrillation potentials and positive sharp waves) on electrophysiological examination
Data sourced from ClinicalTrials.gov (NCT02054247). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.